Among children, rotavirus remains a leading cause of gastroenteritis and, globally, of death. Here's the latest on treatment and prevention, including vaccines in the offing.
Weekly review: New peanut patch data, norovirus outbreaks, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
Study: Nearly 80% of infants born in 2023-24 RSV season received RSV protection
The study within a single health care system revealed that most infants born prior to December received the nirsevimab monoclonal antibody.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
COVID-19 Roundtable: Prophylaxis for the immunocompromised
This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.
Contemporary Pediatrics’ top 3 FDA approvals of 2024
From new topical dermatology treatments for atopic dermatitis to the first nasal spray to treat type 1 allergic reactions, these are our top FDA approvals of 2024.